Saturday, Apr 20 2024 | Time 12:01 Hrs(IST)
image
Business EconomyPosted at: Sep 17 2020 12:43PM


MSN Group announces introduction of 400 mg version of oral antiviral Favilow for COVID treatment

Hyderabad, Sep 17 (UNI) MSN Group (MSN), India’s leading integrated pharmaceutical company, on Thursday announced the introduction a 400 mg version of oral antiviral Favipiravir under brand name Favilow which is most affordable brand for the treatment of mild to moderate COVID-19 patients in India.
Earlier in August, the MSN came up with the world’s most affordable Favipiravir, under the brand name Favilow.
Priced at INR 33, Favilow 200 mg was made available to patients requiring treatment in pharmacies across 170 plus cities.
In order to reduce the pill burden and the overall treatment outcome, MSN has come up with the introduction of Favilow 400 mg version.
The shelf life of the Favilow 200 mg is extended from 3 months to 6 months which would improve pharmacies confidence in stocking the product and ease out availability of the medicine to patients, MSN Group, a Hyderabad-based venture which has nine API and five finished dosage facilities established across Hyderabad and USA, said in a release here.
Explaining the significant development of coming up with higher strength of Favilow, MSN Group Chairman and Managing Director Dr MSN Reddy, said “We have launched the most affordable Favipiravir in order to reduce the cost burden.
We continue to harness our expertise in research & innovation by coming up with treatment options for patients battling with Covid-19.
As part of the COVID 19 treatment range, MSN has already launched Oseltamivir 75 mg capsules, another antiviral medication under the brand name ‘’Oselow’’ Dr Reddy said.
Favilow 400 mg will be available at all the major medical and hospital pharmacies and can be purchased by producing a prescription by a healthcare practitioner at the pharmacies.
Free home delivery is also available in 170 plus cities across the country, the release added.
UNI KNR CS 1242
Please log in to get detailed story.
Tags: #MSN Group announces introduction of 400 mg version of oral antiviral Favilow for COVID treatment
More News

"CSIR-IICT and BHEL partners to advance clean fuel technology: MoU signed on CO2 to DME"

19 Apr 2024 | 7:23 PM

Hyderabad, April 19 (UNI) The Council of Scientific and Industrial Research-Indian Institute of Chemical Technology (CSIR-IICT) and Bharat Heavy Electricals Limited (BHEL) Corporate R&D have forged a partnership to develop technology for capturing and converting carbon dioxide (CO2) to Dimethyl Ether (DME) through direct catalytic conversion.

see more..

Amara Raja Infra Wins Greenko’s 700MWp solar project in AP

19 Apr 2024 | 6:41 PM

Hyderabad, Apr 19 (UNI) Amara Raja Infra Private Limited (ARIPL), part of the $1.75 billion Amara Raja Group, on Friday announced it has secured a solar BoS (Balance of System) project of 500MW/700MWp from Greenko.

see more..
Sensex recovers 600 points on heavy buying on last day of week

Sensex recovers 600 points on heavy buying on last day of week

19 Apr 2024 | 5:34 PM

Mumbai, April 19 (UNI) Snapping a losing streak of last four sessions, the BSE Sensex on Friday bounced back 599.34 points to close at 73088.33 on expectation of minimal escalation of tension between Israel and Iran.

see more..

19 Apr 2024 | 5:24 PM

Mumbai, Apr 19 (UNI) IT major Wipro on Friday reported 7.80% year-on-year dip in consolidated net profit at Rs 2,834.6 crore for January-March quarter (Q4) of the financial year 2023-24.

see more..
Rupee up 8 paise against USD

Rupee up 8 paise against USD

19 Apr 2024 | 5:05 PM

Mumbai, April 19 (UNI) The Rupee on Friday ended positive at 83.47, rising 8 paise against the USD on selling US Dollar by bankers and exporters, dealers at the Foreign exchange said.

see more..
image